New Ask Claude or ChatGPT about any stock, using Bullpen. Bullpen in Claude or ChatGPT. 7 days free
Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Friday, November 13, 2026

Back to the front page

From X

@StableBread

Fajasy on X

Fuel Tech $FTEK, the power plant pollution-control company, nearly tripled its air pollution control (APC) backlog this year, but none of the new awards came from data centers. APC backlog reached $16.6M as of September 30, up from $14.3M as of June 30 and $7.0M as of December 31, and the $3.3M of APC contracts announced with the results take it to $19.9M. In my August 27 deep dive, I said a first data center order or signed capacity reservation could land by the end of Q3. But none of 2026’s announced awards is a data center order, and neither the Q3 release, the 10-Q, nor the Q3 call mentions the reservation agreement management said in August it was negotiating with a potential data center customer. CEO Ramesh Nuggihalli did call the data center opportunity “significant” on the call, and said the 2027 budget factors in “some of the mega project bidding” that’s still underway. I don’t think management misled anyone, since it only called a Q3 award “a possibility.” But data center awards $FTEK hinted at have now failed to land in two straight quarters, so don’t be surprised if the data center option doesn’t come by Q4.
@aleabitoreddit

Serenity on X

Various commentary from Qualcomm, Arm, to Meta executives this week during the AI selloff: $LITE CEO: "You had a comment from the CEO of $IREN and I'd second that. There's a massive disconnect in what we're seeing in our demand books. And what the markets are showing. And yet you're seeing a massive, massive selloff." (Fri, Nov 6) $AMD CEO CNBC: "We're at the very beginning of the adoption cycle, where people can see where AI and superintelligence will take us" "We are seeing demand being higher than supply" (Wed, Nov 4) $ARM CEO regarding a debate whether AI infrastructure spending is about to peak: "I think in some states where it gets harder, other states may pick it up to make it easier, but I do believe strongly that if the US hesitates in any way shape performance in terms of data center buildout... "The rest of the world is ready and willing. There is just huge demand for this capacity. And I think globally the US really wants to be able to compete against China. China is not slowing down at all." (Thu, Nov 5) $APLD CEO: Bank construction lending, project financing and bond markets remain available, although interest rates and credit spreads have risen "The big risk is delivering on time." "The demand picture is extremely robust." (Mon, Nov 2) $QCOM CEO: "It's not demand bound. It's a supply bound." "We're short on wafers, we're short on substrate, we're short on assembly. Everything is short because demand is very, very high." "I think what the market is reacting to is what is the speed of the compute build out." $META on political risk: "We did have a governor that won last night who did make data centers a big part of the platform. Say as soon as we get past the inauguration, let's meet because we don't want to lose this investment in our town. We don't want these jobs to go elsewhere." (Wed, Nov 4) Even politicians campaigning against data centers are negotiating. But Meta's president also emphasized that starting new US DCs will become more difficult. TLDR: -> Extremely bullish commentary from accelerator players, networking, and semi companies -> DC developers report strong pricing/demand, but increasingly emphasize financing, permitting and execution risks (more cautious) -> Politicians that previously campaigned against DCs are showing cooperation There's an important difference between demand disappearing and demand being delayed by the inability to build fast enough. Despite the severity of the selloff, I'm not seeing evidence of widespread AI demand destruction in commentary.
@StableBread

Fajasy on X

Toast $TOST, the restaurant software and payments company, reported its most profitable quarter yet on Tuesday, in the same 8-K that announced President and CFO Elena Gomez is stepping down. I bought $TOST as a long-term hold when I wrote it up on June 2 at $24/share. It closed Friday at $34.67, up 44.5% since then, and 3.4% above its $33.53 close before the report. Here’s what stood out in the Q3 report: → Locations: ~8,500 net adds, taking 2026 to ~25,000 through September (~7,000 in Q1 and ~9,500 in Q2), ahead of the 30,000/year pace my thesis requires. Total locations reached ~189,000, up 21%. → Recurring gross profit: Up 27% to $642M (non-GAAP subscription and fintech gross profit). $TOST’s total take rate (recurring gross profit as a share of the payment volume it processes) rose to 1.04% from 0.98% a year ago, per Gomez on the Q3 call. → Profit: GAAP operating income nearly doubled to $165M from $84M, and net income rose to $169M from $105M, or $0.29/diluted share. → Adjusted EBITDA: $240M, above the $210-220M guide and up from $176M a year ago. → Free cash flow: $181M, up from $153M, but only 75% of adjusted EBITDA, since $TOST chose to buy and hold more hardware inventory (due to rising memory prices). Gomez expects conversion to improve in Q4. → Buybacks: None in Q3, after $486M in H1 2026, with ~$100M left on the authorization. $TOST also raised its full-year adjusted EBITDA guide for the third time in 2026, to $840-850M, and now expects recurring gross profit to grow 26% (up from 23-25%). Safe to say the core business is running ahead of my thesis.

Investor Letters

All letters

QXO Inc Earnings Update: Q3 2026

QXO's Q3 sales rose 79% to $4.9 billion after TopBuild and Kodiak acquisitions, while acquisition debt lifted interest expense to $163…

QXO $13B
SixSigmaCapital: Navigating the Financial Markets 2 clicks

IEH Corporation: Research Note

IEH Corporation posted Q2 revenue growth of 51% to $10.7 million and a record $56 million backlog, led by defense and medical demand.

IEHC $78M
Atrium Research - Equity Research 1 click

Qure Anniversary Update

UniQure’s Huntington’s disease BLA has a May 1, 2027 priority-review date, with an FDA advisory committee expected in late first quarter.

QURE $1.7B
Triple S Special Situations Investing 2 clicks

Publications we follow

Every publication on this site, hand-picked.

130 publications

Newsletters 110

YouTube 4

Blogs 15

Seeking Alpha 88 of 289

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

91 accounts
Nominate an account

Investor letters we follow

376 firms

Sectors

Ordered by how often our editor reaches for them.